These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 30650417)
1. No Evidence of Microsatellite Instability and Loss of Mismatch-Repair-Protein Expression in Squamous Cell Carcinoma of the Penis. Stoehr R; Wendler O; Giedl J; Gaisa NT; Richter G; Campean V; Burger M; Wullich B; Bertz S; Hartmann A Pathobiology; 2019; 86(2-3):145-151. PubMed ID: 30650417 [TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger. Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706 [TBL] [Abstract][Full Text] [Related]
3. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes. Mead LJ; Jenkins MA; Young J; Royce SG; Smith L; St John DJ; Macrae F; Giles GG; Hopper JL; Southey MC Clin Cancer Res; 2007 May; 13(10):2865-9. PubMed ID: 17504984 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Three Customized MSI Panels to Improve the Detection of Microsatellite Instability in Gastric Cancer. Park J; Shin S; Yoo HM; Lee SW; Kim JG Clin Lab; 2017 Apr; 63(4):705-716. PubMed ID: 28397474 [TBL] [Abstract][Full Text] [Related]
5. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability. Aysal A; Karnezis A; Medhi I; Grenert JP; Zaloudek CJ; Rabban JT Am J Surg Pathol; 2012 Feb; 36(2):163-72. PubMed ID: 22189970 [TBL] [Abstract][Full Text] [Related]
6. High homogeneity of MMR deficiency in ovarian cancer. Fraune C; Rosebrock J; Simon R; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Büscheck F; Höflmayer D; Schmalfeldt B; Müller V; Wölber L; Witzel I; Paluchowski P; Wilke C; Heilenkötter U; von Leffern I; Clauditz TS; Wilczak W; Sauter G; Steurer S; Burandt E Gynecol Oncol; 2020 Mar; 156(3):669-675. PubMed ID: 31924330 [TBL] [Abstract][Full Text] [Related]
7. Tissue expression of MLH1, PMS2, MSH2, and MSH6 proteins and prognostic value of microsatellite instability in Wilms tumor: experience of 45 cases. Diniz G; Aktas S; Cubuk C; Ortac R; Vergin C; Olgun N Pediatr Hematol Oncol; 2013 May; 30(4):273-84. PubMed ID: 23570624 [TBL] [Abstract][Full Text] [Related]
8. A comparison of performance of 6-mononucleotide site panel and NCI panel for microsatellite instability detection in patients with colorectal adenocarcinoma. He L; Yang J; Zhang B; Wang Y; Wang J; Ye Q Pathol Res Pract; 2023 Apr; 244():154390. PubMed ID: 36905693 [TBL] [Abstract][Full Text] [Related]
9. [Value of detection of DNA mismatch repair proteins deficiency by immunohistochemistry in predicting tumor microsatellite status]. Qin Y; Liang L; Zheng X; Zheng J; Ye J; Guo L; Zhao F; Shi X Zhonghua Bing Li Xue Za Zhi; 2015 Oct; 44(10):704-8. PubMed ID: 26702526 [TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer. Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581 [TBL] [Abstract][Full Text] [Related]
11. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. Luchini C; Bibeau F; Ligtenberg MJL; Singh N; Nottegar A; Bosse T; Miller R; Riaz N; Douillard JY; Andre F; Scarpa A Ann Oncol; 2019 Aug; 30(8):1232-1243. PubMed ID: 31056702 [TBL] [Abstract][Full Text] [Related]
12. Enhanced detection of microsatellite instability and mismatch repair gene expression in cutaneous squamous cell carcinomas. Gray SE; Kay EW; Leader M; Mabruk MJ Mol Diagn Ther; 2006; 10(5):327-34. PubMed ID: 17022696 [TBL] [Abstract][Full Text] [Related]